{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T04:16:05Z","timestamp":1682914565781},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High-flow continuous hemodiafiltration (HF-CHDF) combines diffusive and convective solute removal and is employed for artificial liver adjuvant therapy. However, there is no report on dosage planning of vancomycin (VCM) in patients with acute liver failure under HF-CHDF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 20-year-old woman (154\u2009cm tall, weighing 50\u2009kg) was transferred to the intensive care unit (ICU) with acute liver failure associated with autoimmune liver disease. On the following day, HF-CHDF was started due to elevated plasma ammonia concentration. On ICU day 8, VCM was started for suspected pneumonia and meningitis (30\u2009mg\/kg loading dose, then 20\u2009mg\/kg every 12\u2009hrs). However, on ICU day 10, VCM blood concentration was under the limit of detection (&lt;\u20093.0\u2009\u03bcg\/mL) and the patient developed anuria. The VCM dose was increased to 20\u2009mg\/kg every 6\u2009hrs. Calculation with a one-compartment model using the HF-CHDF blood flow rate as a surrogate for VCM clearance, together with hematocrit and protein binding ratio, predicted a trough VCM blood concentration of 15\u2009\u03bcg\/mL. The observed concentration was about 12\u2009\u03bcg\/mL. The difference may represent non-HF-CHDF clearance. Finally, living donor liver transplantation was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We report an acute liver failure patient with anuria under HF-CHDF in whom VCM administration failed to produce an effective blood concentration, likely due to HF-CHDF-enhanced clearance. VCM dosage adjustment proved successful, and was confirmed by calculation using a one-compartment model.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40780-023-00283-0","type":"journal-article","created":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T23:04:17Z","timestamp":1682895857000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: therapeutic monitoring of vancomycin in an acute liver failure patient with anuria under high-flow continuous hemodiafiltration"],"prefix":"10.1186","volume":"9","author":[{"given":"Yuriko","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Nakade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Gabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nakanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arimi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimichi","family":"Sai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"283_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000314854","volume":"166","author":"H Shinozaki","year":"2010","unstructured":"Shinozaki H, Oda S, Abe R, et al. Blood purification in fulminant hepatic failure. Contrib Nephrol. 2010;166:64\u201372. https:\/\/doi.org\/10.1159\/000314854. Epub 2010 May 7","journal-title":"Contrib Nephrol"},{"issue":"11","key":"283_CR2","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/j.1525-1594.1996.tb00657.x","volume":"20","author":"M Yoshiba","year":"1996","unstructured":"Yoshiba M, Inoue K, Sekiyama K, et al. Favorable effect of new lover support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20(11):1169\u201372. https:\/\/doi.org\/10.1111\/j.1525-1594.1996.tb00657.x.","journal-title":"Artif Organs"},{"key":"283_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-227X-10-10","volume":"10","author":"S Arata","year":"2010","unstructured":"Arata S, Tanaka K, Takayama K, et al. Treatment of hepatic encephalopathy by on-line hemodiafiltration: a case series study. BMC Emerg Med. 2010;10:10. https:\/\/doi.org\/10.1186\/1471-227X-10-10.","journal-title":"BMC Emerg Med"},{"issue":"8","key":"283_CR4","doi-asserted-by":"publisher","first-page":"e00583","DOI":"10.1128\/AAC.00583-19","volume":"63","author":"V Pistolesi","year":"2019","unstructured":"Pistolesi V, Morabito S, Mario F, et al. A guide to understanding antimicrobial drug dosing in critically ill patients on renal replacement therapy. Antimicrob Agents Chemother. 2019;63(8):e00583\u201319. https:\/\/doi.org\/10.1128\/AAC.00583-19. Print 2019 Aug","journal-title":"Antimicrob Agents Chemother."},{"issue":"5","key":"283_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/1744-9987.12675","volume":"22","author":"M Urata","year":"2018","unstructured":"Urata M, Narita Y, Fukunaga M, et al. Simple formula for predicting drug removal rates during hemodialysis. Ther Apher Dial. 2018;22(5):485\u201393. https:\/\/doi.org\/10.1111\/1744-9987.12675. Epub 2018 Jul 10","journal-title":"Ther Apher Dial"},{"key":"283_CR6","first-page":"35","volume-title":"Vancomycin: TDM Guideline for Antibiotics, the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Revised version","author":"Y Takesue","year":"2016","unstructured":"Takesue Y, Omagari T, Okada K, et al. Vancomycin: TDM Guideline for Antibiotics, the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Revised version. Tokyo: KYORINSHA; 2016. p. 35\u201358."},{"issue":"4","key":"283_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5507\/bp.2012.002","volume":"156","author":"N Petejova","year":"2012","unstructured":"Petejova N, Martinek A, Zahalkova J, et al. Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156(4):342\u20137. https:\/\/doi.org\/10.5507\/bp.2012.002. Epub 2012 Jan 30","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"4","key":"283_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/cid\/cis458","volume":"55","author":"SA Zelenitsky","year":"2012","unstructured":"Zelenitsky SA, Ariano RE, McCrae ML, et al. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis. Clin Infect Dis. 2012;55(4):527\u201333. https:\/\/doi.org\/10.1093\/cid\/cis458. Epub 2012 May 9","journal-title":"Clin Infect Dis"},{"issue":"12","key":"283_CR9","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1128\/AAC.00459-12","volume":"56","author":"EN Frazee","year":"2012","unstructured":"Frazee EN, Kuper PJ, Schramm GE, Larson SL, Kashani KB, Osmon DR, et al. Effect of continuous venovenous hemofiltration dose on achievement of adequate vancomycin trough concentrations. Antimicrob Agents Chemother. 2012;56(12):6181\u20135. https:\/\/doi.org\/10.1128\/AAC.00459-12. Epub 2012 Sep 17","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"283_CR10","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/jcpt.13197","volume":"45","author":"M Tsuruyama","year":"2020","unstructured":"Tsuruyama M, Yamashina T, Tsuruta M, et al. Vancomycin pharmacokinetics in critically ill patients receiving continuous haemodiafiltration with a polyethyleneimine-coated polyacrylonitrile membrane. J Clin Pharm Ther. 2020;45(5):1143\u20138. https:\/\/doi.org\/10.1111\/jcpt.13197. Epub 2020 Jun 4","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"283_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/MAT.0b013e3182306196","volume":"57","author":"KI Sombolos","year":"2011","unstructured":"Sombolos KI, Fragidis SK, Bamichas GI, et al. Subtherapeutic serum vancomycin concentration during on-line hemodiafiltration. ASAIO J. 2011;57(6):507\u201310. https:\/\/doi.org\/10.1097\/MAT.0b013e3182306196.","journal-title":"ASAIO J"},{"issue":"4","key":"283_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jgh.12440","volume":"29","author":"T Komura","year":"2014","unstructured":"Komura T, Taniguchi T, Sakai Y, et al. Efficacy of continuous plasma diafiltration therapy in critical patients with acute liver failure. J Gastroenterol Hepatol. 2014;29(4):782\u20136. https:\/\/doi.org\/10.1111\/jgh.12440.","journal-title":"J Gastroenterol Hepatol"},{"key":"283_CR13","first-page":"210","volume":"40","author":"M Nakashima","year":"1992","unstructured":"Nakashima M, Katagiri K, Oguma T. Phase I studies on vancomycin hydrochloride for injection. Chemotherapy. 1992;40:210\u201324.","journal-title":"Chemotherapy"},{"issue":"3","key":"283_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/FTD.0000000000000500","volume":"40","author":"P Lewis","year":"2018","unstructured":"Lewis P. Vancomycin area under the curve simplified. Ther Drug Monit. 2018;40(3):377\u201380. https:\/\/doi.org\/10.1097\/FTD.0000000000000500.","journal-title":"Ther Drug Monit"},{"issue":"12","key":"283_CR15","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1128\/AAC.01758-10","volume":"55","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T, Yasuno N, Katada S, et al. Proposal of pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration. Antimicrob Agents Chemother. 2011;55(12):5804\u201312. https:\/\/doi.org\/10.1128\/AAC.01758-10. Epub 2011 Sep 12","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"283_CR16","first-page":"3","volume":"3","author":"T Yamamoto","year":"2014","unstructured":"Yamamoto T, Hisaka A, Suzuki H. Principle of dosage adjustment for patients receiving continuous renal replacement therapy (CRRT) based on the quantitative estimation of clearance by CRRT. Jpn J Nephrol Pharmacother. 2014;3(1):3\u201319.","journal-title":"Jpn J Nephrol Pharmacother"},{"key":"283_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40780-015-0031-6","volume":"1","author":"G Akashita","year":"2015","unstructured":"Akashita G, Hosaka Y, Noda T, et al. PK\/PD analysis of biapenem in patients undergoing continuous hemodiafiltration. J Pharm Health Care Sci. 2015;1:31. https:\/\/doi.org\/10.1186\/s40780-015-0031-6. eCollection 2015","journal-title":"J Pharm Health Care Sci"},{"issue":"3","key":"283_CR18","first-page":"670","volume":"24","author":"M Mineshima","year":"1995","unstructured":"Mineshima M, Hoshino T, Teraoka S, et al. Effect of dilution modality and filtration flow rate on solute removal characteristics in HF and HDF with high ultrafiltration. Jpn J Artif Organs. 1995;24(3):670\u20135.","journal-title":"Jpn J Artif Organs"},{"key":"283_CR19","first-page":"2868","volume-title":"United States Pharmacopeial Convention: Drug Information for the Health Care Professional 27th edition","author":"Thomson Micromedex","year":"2007","unstructured":"Thomson Micromedex. United States Pharmacopeial Convention: Drug Information for the Health Care Professional 27th edition, vol. I; 2007. p. 2868."},{"issue":"3","key":"283_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1128\/AAC.22.3.391","volume":"22","author":"JC Rotschafer","year":"1982","unstructured":"Rotschafer JC, Crossley K, Zaske DE, et al. Pharmacokinetics of vancomycin: observation in 28 patients and dosage recommendations. Antimicrob Agents Chemother. 1982;22(3):391\u20134. https:\/\/doi.org\/10.1128\/AAC.22.3.391.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"283_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/psp4.12279","volume":"7","author":"C Emoto","year":"2018","unstructured":"Emoto C, Johnson TN, McPhail BM, et al. Using a vancomycin PBPK model in special populations to elucidate case-based clinical PK observations. CPT Pharmacometrics Syst Pharmacol. 2018;7(4):237\u201350. https:\/\/doi.org\/10.1002\/psp4.12279. Epub 2018 Feb 15","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"283_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s101560050018","volume":"5","author":"H Harada","year":"1999","unstructured":"Harada H, Miyagawa S, Kawasaki S, et al. Study of the pharmacokinetics of vancomycin in patients with impaired liver function. J Infect Chemother. 1999;5(2):104\u20137. https:\/\/doi.org\/10.1007\/s101560050018.","journal-title":"J Infect Chemother"},{"issue":"5","key":"283_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/sj.bjp.0707251","volume":"151","author":"K Oettl","year":"2007","unstructured":"Oettl K, Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol. 2007;151(5):580\u201390. https:\/\/doi.org\/10.1038\/sj.bjp.0707251. Epub 2007 Apr 30","journal-title":"Br J Pharmacol"},{"issue":"1","key":"283_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41598-018-37195-1","volume":"9","author":"V Maheshwari","year":"2019","unstructured":"Maheshwari V, Thijssen S, Tao X, et al. In silico comparison of protein-bound uremic toxin removal by hemodialysis, hemodiafiltration, membrane adsorption, and binding competition. Sci Rep. 2019;9(1):909. https:\/\/doi.org\/10.1038\/s41598-018-37195-1.","journal-title":"Sci Rep"},{"issue":"11","key":"283_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835\u201364. https:\/\/doi.org\/10.1093\/ajhp\/zxaa036.","journal-title":"Am J Health Syst Pharm"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-023-00283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-023-00283-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-023-00283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T23:07:02Z","timestamp":1682896022000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-023-00283-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1186\/s40780-023-00283-0","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"15 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since this is a case report, ethical approval was deemed unnecessary by the Medical Ethics Committee of Kanazawa University. Verbal consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}